Thursday, November 22, 2007
UPDATED: FDA to investigate Chantix anti-smoking drug that Dallas musician Carter Albrecht took
Updated 11:30 a.m., December 14, 2007
The FDA announced that it will begin collecting information about anti-smoking drug Chantix after having received reports of mood disorders and erratic behavior among patients taking it.
Chantix is the drug that Dallas musician Carter Albrecht was taking when he was shot and killed September 3. Investigators were unable to test for Chantix; an autopsy report showed he had a blood alcohol level of 0.29 when he died. But his death spurred the FDA to dig deeper, requesting that manufacturer Pfizer provide reports of any incidents "similar to the events that occurred with Mr. Albrecht."
UPDATE: Some of the more extreme reactions to Chantix also include suicidal tendencies. Most recently, television editor Omer Jama slashed his wrists while taking the drug and the number of people in the U.K. taking the British counterpart, Champix, who reported having suicidal thoughts doubled in the last two months.
Suicidal thoughts and Chantix
Posted by T.G., Updated by Erin
Email
|
Print
|
Comment
|
Tell us your story
|
-
»Dallas County to launch new prescription drug savings program
-
»Dallas jury returns $1.9 million verdict against Carrollton-based nutritional supplement provider AdvoCare
-
»Coppell-based Mannatech expanding to four additional European countries
-
»Dallas-based ACS acquires Pharm/DUR
-
»Coppell-based Mannatech reaches settlement with Texas Attorney General over deceptive trade practices
